Seasoned private markets executive with multidisciplinary background in corporate finance, operations and strategic portfolio management. Leslie Childs brings experience leading growth equity and operational improvement initiatives across technology and healthcare companies. They have worked with sponsor-backed management teams on revenue scaling, capital raising and exit preparation, and sit on operating committees and advisory boards. Market-facing strengths include deal sourcing, diligence, and value-creation planning for mid-market buyouts and growth investments.
Seasoned private markets executive with multidisciplinary background in corporate finance, operations and strategic portfolio management. Leslie Childs brings experience leading growth equity and operational improvement initiatives across technology and healthcare companies. They have worked with sponsor-backed management teams on revenue scaling, capital raising and exit preparation, and sit on operating committees and advisory boards. Market-facing strengths include deal sourcing, diligence, and value-creation planning for mid-market buyouts and growth investments.
Combines disciplined growth-equity investing with operationally-driven value creation, targeting mid-market technology and healthcare companies where revenue scaling and margin improvement are achievable. Prefers sponsor-backed situations and minority or control growth rounds with 3–7 year horizons, deploying capital alongside management while prioritizing rigorous diligence, milestone-based capital pacing and active board-level involvement. Risk management emphasizes concentrated, thesis-driven bets, operational KPIs for value realization, and clear exit pathways via strategic sale or secondary sponsor recapitalization.
Combines disciplined growth-equity investing with operationally-driven value creation, targeting mid-market technology and healthcare companies where revenue scaling and margin improvement are achievable. Prefers sponsor-backed situations and minority or control growth rounds with 3–7 year horizons, deploying capital alongside management while prioritizing rigorous diligence, milestone-based capital pacing and active board-level involvement. Risk management emphasizes concentrated, thesis-driven bets, operational KPIs for value realization, and clear exit pathways via strategic sale or secondary sponsor recapitalization.
| Trades 1998 | Longs Won 1366/1998 68% | Profit Factor 19.22 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $339,718.55 |
| Average Win $47,973.68 | Best Trade (Jul 13) $9.48M | Sharpe Ratio -97.77 |
| Average Loss -$5,394.94 | Worst Trade (Jul 14) -$505,872.83 | Z-Score 19.89 (100%) |
| Commissions $0 | Avg. Trade Length 1y 9m 3w 3d | Expectancy $31,092.31 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 47,619 | 42,857 | 38,095 | 33,333 | 28,571 | 23,810 | 19,048 | 14,286 | 9,524 | 4,762 |